Skip to main content

Table 2 Associations of PAI-1 levels and metabolic parameters, BMD and bone turnover markers; association of L-BMD and metabolic parameters, PAI-1 and bone turnover markers

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

PAI-1

r

p

L-BMD

r

p

Age (year)

−0,2375

0,011

Age (year)

  

BMI (kg/m2)

0,3453

0,000

BMI (kg/m2)

0,347

0,000

Diabetes duration (year)

-0,3046

0,002

Diabetes duration (year)

0,297

0,000

Insulin (mIU/L)

0,4411

0,000

Insulin (mIU/L)

−0,232

0,018

Triglycerides (mmol/L)

0,4704

0,000

Triglycerides (mmol/L)

  

HDL (mmol/L)

-0,3331

0,001

LDL (mmol/L)

-0,1956

0,041

Osteocalcin (ng/ml)

-0,2976

0,002

PAI-1

0,119

0,046

Pyrilinks (nMPD/mMc)

-0,2897

0,002

Osteocalcin (ng/ml)

−0,318

0,001

Crosslaps (ng/ml)

-0,2955

0,002

Pyrilinks (nMPD/mMc)

−0,302

0,001

Lumbar BMD (g/cm2)

0,1990

0,046

Crosslaps (ng/ml)

−0,24

0,012

Hip BMD (g/cm2)

0,3530

0,000

   
  1. PAI 1 plasminogen activator inhibitor 1, BMD bone mineral density, BMI body mass index, HDL high density lipoprotein